Skip to content

Research on effect of Erhuang Decoction in treating radiation skin damage induced by tumor radiotherapy

Research on effect of Erhuang Decoction in treating radiation skin damage induced by tumor radiotherapy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003623
Enrollment
Unknown
Registered
2013-09-14
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radiation-induced skin damage

Interventions

Observing Group:Erhuang Decoction
Controling Group:Biafine Cream

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Available for the patients who have been diagnosed to suffer from malignant tumor pathological or cytologically; 2. Skin damage second or third degree after radiotherapy (According to RTOG Grading Standards); 3. Aged between 18 and 70 years; 4. KPS higher than 60 scores and expected survival is longer than three months; 5. Patients used nothing corticosteroids and antihistamines history thoroughly nearly two weeks and externally history in one week; 6. Volunteer to accept our treatment and sign informed consent; 7. Patients agree wont use other treatments for radiation-induced skin damage during clinical trials.

Exclusion criteria

Exclusion criteria: 1. Not available for thosepatients who do not meet the inclusion criteria; 2. Not available for those patients who have ever suffered form systemic or contact drug allergy; 3. Not available for those patients whose local lesions infected with bacterial or fungal; 4. Not available for those patients who suffer from serious endocrine, cardiovascular, blood, liver and kidney diseases and Immunocompromised; 5. Not available for those patients dangerously ill or survival of less than three months.

Design outcomes

Primary

MeasureTime frame
radiation-induced skin damage Grading;

Countries

China

Contacts

Public ContactWei Hou
houwei1964@sohu.com+86 13701361625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026